MedPath

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Phase 2
Recruiting
Conditions
Systemic Lupus Erythematosus
Interventions
Drug: M5049 low dose
Drug: M5049 medium dose
Drug: M5049 high dose
Drug: Placebo
Drug: M5049 very high dose
Registration Number
NCT05540327
Lead Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Brief Summary

The purpose of the study is to evaluate the long term safety and efficacy of orally administered M5049 in participants with subacute cutaneous lupus erythematosus (SCLE), discoid lupus erythematosus (DLE) and/or systemic lupus erythematosus (SLE) who have completed the 24 week treatment period of Willow study (MS200569_0003 \[NCT05162586\]).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
532
Inclusion Criteria
  • Are active SCLE, DLE and/or SLE that have completed the 24 week Treatment of the Willow Study
  • Have a Body Mass Index (BMI) within the >= 40 kilograms per meter square (inclusive) at Screening
  • Other protocol defined inclusion criteria could apply
Exclusion Criteria
  • Participants who experienced serious event(s) related to the study intervention during the WILLOW study
  • Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with Long Term Extension (LTE) study participation
  • Ongoing or active clinically significant viral (including Severe acute respiratory syndrome coronavirus 2 [(SARS-CoV-2)], bacterial or fungal infection, or any major episode of infection requiring hospitalization
  • Received LTE prohibited medication during the WILLOW study or after the WILLOW study Week 24
  • Participation in any other investigational drug study after the WILLOW study Week 24
  • Other protocol defined exclusion criteria could apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
M5049 low dose + PlaceboM5049 low doseParticipants with CLE (active SCLE and/or DLE) or SLE who received low dose of M5049 in WILLOW study will continue to receive M5049 low dose and matching placebo.
M5049 medium dose+ PlaceboM5049 medium doseParticipants with CLE (active SCLE and/or DLE) or SLE who received medium dose of M5049 in WILLOW study will continue to receive M5049 medium dose and matching placebo.
M5049 high dose + PlaceboPlaceboParticipants with CLE (active SCLE and/or DLE) or SLE who received M5049 matched placebo or high dose of M5049 in WILLOW study will receive M5049 high dose .
M5049 medium dose+ PlaceboPlaceboParticipants with CLE (active SCLE and/or DLE) or SLE who received medium dose of M5049 in WILLOW study will continue to receive M5049 medium dose and matching placebo.
M5049 high dose + PlaceboM5049 high doseParticipants with CLE (active SCLE and/or DLE) or SLE who received M5049 matched placebo or high dose of M5049 in WILLOW study will receive M5049 high dose .
M5049 very high dose + PlaceboM5049 very high doseParticipants with CLE (active SCLE and/or DLE) or SLE who received M5049 matched placebo or very high dose of M5049 in WILLOW study will receive M5049 very high dose.
M5049 low dose + PlaceboPlaceboParticipants with CLE (active SCLE and/or DLE) or SLE who received low dose of M5049 in WILLOW study will continue to receive M5049 low dose and matching placebo.
M5049 very high dose + PlaceboPlaceboParticipants with CLE (active SCLE and/or DLE) or SLE who received M5049 matched placebo or very high dose of M5049 in WILLOW study will receive M5049 very high dose.
Primary Outcome Measures
NameTimeMethod
Safety Profile as Assessed by Incidence of Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs), Adverse Event of Special Interest (AESIs)Baseline up to Week 50
Secondary Outcome Measures
NameTimeMethod
Number of Participants with Abnormalities in Laboratory Parameters and QT Interval CorrectedBaseline up to Week 50
Percent Change from WILLOW Study Baseline in Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI-A) at Weeks 0, 2, 4, 12, 24, 36 and 48Baseline (WILLOW study), Weeks 0, 2, 4, 12, 24, 36 and 48
Number of Participants With Based Composite Lupus Assessment (BICLA) ResponseAt Weeks 24 and 48
Change from WILLOW Study Baseline in Cutaneous Lupus Activity Investigator's Global Assessment (CLA-IGA) at Weeks 0, 2, 4, 12, 24, 36 and 48Baseline (WILLOW study), Weeks 0, 2, 4, 12, 24, 36 and 48
Number of Participants With Systemic lupus Erythematosus Responder Index-4 (SRI-4) ResponseAt Weeks 24 and 48

Trial Locations

Locations (121)

Advance Medical Research Center

🇺🇸

Miami, Florida, United States

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Dawes Fretzin Dermatology Group, LLC

🇺🇸

Indianapolis, Indiana, United States

Veracity Clinical Research

🇦🇺

Woolloongabba, Australia

The Lundquist Institute at Harbor-UCLA Medical Center

🇺🇸

Torrance, California, United States

Ohio State University - CTMO Parent

🇺🇸

Columbus, Ohio, United States

Hainan General Hospital

🇨🇳

Haikou, China

Peking Union Medical College Hospital - Beijing Union Medical College Hospital

🇨🇳

Beijing, China

The First Hospital of Jilin University

🇨🇳

Changchun, China

Renji Hospital Shanghai Jiaotong University School of Medicine - West Branch

🇨🇳

Shanghai, China

The First Affiliated Hospital of Soochow University

🇨🇳

Suzhou, China

The First Affiliated Hospital of Xi'an Jiaotong University

🇨🇳

Xi'an, China

Saitama Medical Center - Dept of Rheumatology/Immunology

🇯🇵

Kawagoe-shi, Japan

Kagawa University Hospital - Dept of Immunology/ Rheumatology

🇯🇵

Kita-gun, Japan

Hospital General de Castellon - Servicio de Reumatologia

🇪🇸

Castello, Spain

Arthritis Clinical Research Trial Unit - Dr CE Spargo and Dr RB Bhorat

🇿🇦

Cape Town, South Africa

Hospital Universitario Marques de Valdecilla - Servicio de Reumatologia

🇪🇸

Santander, Spain

Hospital Regional Universitario de Malaga - Reumatology Dept

🇪🇸

Malaga, Spain

Naidoo, A - Netcare Umhlanga Hospital

🇿🇦

Umhlanga, South Africa

University of Pretoria Clinical Research Unit - Parent

🇿🇦

Pretoria, South Africa

Monash Medical Centre Clayton

🇦🇺

Clayton, Australia

Santa Casa de Misericórdia de Belo Horizonte

🇧🇷

Belo Horizonte, Brazil

Oncovida - Centro de Onco-Hematologia de Mato Grosso

🇧🇷

Cuiabá, Brazil

CEPIC - Centro Paulista de Investigação Clínica e Serviços Médicos

🇧🇷

Sao Paulo, Brazil

Clinica Alemana de Osorno - Corporacion de Beneficencia Osorno

🇨🇱

Los Lagos, Chile

UMHAT "Sv. Ivan Rilski", EAD - Clinic of Rheumatology

🇧🇬

Sofia, Bulgaria

UMHAT "Sv. Ivan Rilski", EAD - Clinica of Rheumatology

🇧🇬

Sofia, Bulgaria

CIEC- Centro Internacional de Estudios Clinicos - Valenzuela Y Compania Ltda

🇨🇱

Santiago, Chile

CeCim Biocinetic

🇨🇱

Santiago, Chile

The First Affiliated Hospital of Baotou Medical College

🇨🇳

Baotou, China

Dermacross

🇨🇱

Santiago, Chile

Guangdong Provincial People's Hospital

🇨🇳

Guangzhou, China

The Second Affiliated Hospital of Nanchang University

🇨🇳

Nanchang, China

The First Affiliated Hospital of Henan University of Science and Technology

🇨🇳

Luoyang, China

West China Hospital, Sichuan University

🇨🇳

Sichuan, China

Huashan Hospital, Fudan University - Neurology

🇨🇳

Shanghai, China

Shanghai Skin Disease Hospital

🇨🇳

Shanghai, China

Tianjin Medical University General Hospital

🇨🇳

Tianjin, China

Healthy Medical Center

🇨🇴

Zipaquirá, Colombia

Chaim Sheba Medical Center - pt

🇮🇱

Ramat Gan, Israel

Diseño y Planeacion en Investigacion Medica S.C.

🇲🇽

Guadalajara, Mexico

Consultorio de Reumatologia - Hospital Angeles Lindavista Cons. 445B

🇲🇽

Mexico, Mexico

Centro de Investigacion Clínica GRAMEL S.C

🇲🇽

Mexico, Mexico

S.C Delta Health Care S.R.L - Ponderas Academic Hospital

🇷🇴

Bucuresti, Romania

Hospital Universitario Rio Hortega - Servicio de Medicina Interna

🇪🇸

Valladolid, Spain

Twoja Przychodnia PCM

🇵🇱

Poznan, Poland

CINME - Centro De Investigaciones Metabolicas

🇦🇷

Ciudad Autonoma de Buenos Aires, Argentina

Instituto Medico de alta Complejidad San Isidro S.A (IMAC)

🇦🇷

San Fernando, Argentina

Centro de Investigaciones Medicas Tucuman

🇦🇷

Tucuman, Argentina

MC Artmed OOD

🇧🇬

Plovdiv, Bulgaria

DCC 1 Sevlievo EOOD

🇧🇬

Sevlievo, Bulgaria

Military Medical Academy - MHAT - Sofia

🇧🇬

Sofia, Bulgaria

Bay Area Arthritis and Osteoporosis

🇺🇸

Brandon, Florida, United States

PSORIAHUE-Medicina Interdisciplinar

🇦🇷

San Miguel, Argentina

Clínica SER da Bahia

🇧🇷

Graca, Brazil

DCC Focus 5 - MEOH OOD

🇧🇬

Sofia, Bulgaria

Centro de Investigacion Medico Asistencial S.A.S

🇨🇴

Barranquilla, Colombia

NHO Chibahigashi National Hospital - Dept of Allergy/Rheumatology

🇯🇵

Chiba-shi, Japan

Hiroshima University Hospital

🇯🇵

Hiroshima-shi, Japan

Tohoku University Hospital - Dept of Hematology/Immunology

🇯🇵

Sendai-shi, Japan

Iloilo Doctors Hospital

🇵🇭

Iloilo City, Philippines

Chinese General Hospital & Medical Center

🇵🇭

Manila, Philippines

Prywatna Praktyka Lekarska prof Pawel Hrycaj

🇵🇱

Koscian, Poland

Centrum Medyczne Plejady

🇵🇱

Kraków, Poland

Centro de Investigaciones Medicas Mar del Plata - CIM

🇦🇷

Mar del Plata, Argentina

CER San Juan Centro Polivalente de Asistencia e Inv. Clinica

🇦🇷

San Juan, Argentina

Investigaciones Clinicas Tucuman

🇦🇷

San Miguel de Tucuman, Argentina

Centro Dermatologico Schejtman

🇦🇷

San Miguel, Argentina

CMiP - Centro Mineiro de Pesquisa

🇧🇷

Juiz de Fora, Brazil

DCC 'Sveti Georgi' EOOD - Cardiology Office

🇧🇬

Haskovo, Bulgaria

Centro Medico Prosalud

🇨🇱

Santiago, Chile

General Hospital Papageorgiou

🇬🇷

Thessaloniki, Greece

NHO Asahikawa Medical Center - Dept of Gastroenterology

🇯🇵

Asahikawa-shi, Japan

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

AA MRC LLC Ahmed Arif Medical Research Center

🇺🇸

Grand Blanc, Michigan, United States

Buenos Aires Skin

🇦🇷

Ciudad Autonoma Buenos Aires, Argentina

Hospital Militar Central Dr. Cosme Argerich

🇦🇷

Ciudad Autonoma Buenos Aires, Argentina

Instituto de Reumatologia

🇦🇷

Mendoza, Argentina

Hospital Moinhos de Vento

🇧🇷

Moinhos de Vento, Brazil

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto - CIP - Centro Integrado de Pesquisa

🇧🇷

Sao Jose, Brazil

BioMedica Research Group - Psicomedica Clinical and Research Group

🇨🇱

Santiago, Chile

Servimed S.A.S.

🇨🇴

Bucaramanga, Colombia

Hokkaido University Hospital - Dept of Internal Medicine 2(Rheumatology/Immunolog

🇯🇵

Sapporo-shi, Japan

Diseno y Planeacion en Investigacion Medica S.C.

🇲🇽

Guadalajara, Mexico

Clinical Best Solutions - Warszawa

🇵🇱

Warszawa, Poland

Centrul Medical Monza SRL - Arensia Exploratory Medicine

🇷🇴

Bucharest, Romania

Institute of Rheumatology

🇷🇸

Belgrade, Serbia

Ramesh C Gupta, MD

🇺🇸

Memphis, Tennessee, United States

Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS

🇨🇴

Medellin, Colombia

General Hospital of Athens Laiko

🇬🇷

Athens, Greece

Ajou University Hospital

🇰🇷

Suwon, Korea, Republic of

Consultorio Privado Dr. Miguel Cortes Hernandez

🇲🇽

Cuernavaca, Mexico

Centro de Estudios de Investigacion Basica y Clinica SC

🇲🇽

Guadalajara, Mexico

Centro Medico del Angel

🇲🇽

Mexicali, Mexico

Far Eastern University - Dr. Nicanor Reyes Medical Foundation - Department of Child Health

🇵🇭

Quezon City, Philippines

Nova Reuma Domysławska i Rusiłowicz, Spółka Partnerska Lekarza Reumatologa i Fizjoterapeuty

🇵🇱

Bialystok, Poland

Spitalul Clinic "Sf. Maria" - Clinica de Medicina Interna si Reumatologie

🇷🇴

Bucuresti, Romania

Spitalul Clinic "Sf. Maria" - parent

🇷🇴

Bucuresti, Romania

Kaohsiung Chang Gung Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Taipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

Centro de Investigacion en Reumatologia y Especialidades Medicas SAS. CIREEM

🇨🇴

Bogotá, Colombia

St. Luke's International Hospital - Dept of Immunology/Allergy

🇯🇵

Chuo-ku, Japan

Eiraku Clinic - Dept of Rheumatology

🇯🇵

Kagoshima-shi, Japan

Gachon University Gil Medical Center

🇰🇷

Incheon, Korea, Republic of

Clinstile, S.A. de C.V.

🇲🇽

Ciudad de México, Mexico

Medical Care & Research SA de CV

🇲🇽

Merida, Mexico

Clinica para el Diagnostico y Tratamiento de las Enfermedades Reumaticas

🇲🇽

Mexico, Mexico

Grupo Medico Camino S.C.

🇲🇽

Mexico, Mexico

CIMAB S.A. de C.V. - Centro de Investigacion Medica Alberto Bazzoni

🇲🇽

Torreon, Mexico

University Clinical Center of Serbia - Clinic of Alergology and Imunology

🇷🇸

Belgrade, Serbia

CAP Research Ltd

🇲🇺

Quatre Bornes, Mauritius

CAIMED Investigacion en salud S.A de C.V.

🇲🇽

Ciudad de México, Mexico

Centro Regiomontano de Estudios Clínicos Roma S.C.

🇲🇽

Monterrey, Mexico

ICS ARENSIA Exploratory Medicine SRL - Republican Clinical Hospital "Timofei Mosneaga"

🇲🇩

Chisinau, Moldova, Republic of

Davao Doctors Hospital - Medicine

🇵🇭

Davao City, Philippines

Mary Mediatrix Medical Center

🇵🇭

Lipa City, Philippines

Ospital Ng Makati

🇵🇭

Makati City, Philippines

Centrum Nowoczesnych Terapii Dobry Lekarz

🇵🇱

Krakow, Poland

Institute of Rheumatology - Rheumatology

🇷🇸

Belgrade, Serbia

Twoja Przychodnia-Szczecinskie Centrum Medyczne Sp. z o. o

🇵🇱

Szczecin, Poland

The Affiliated Drum Tower Hospital of Nanjing University

🇨🇳

Nanjing, China

© Copyright 2025. All Rights Reserved by MedPath